 |
When and where was the Company incorporated? From when is the Company widely held, with public participation?
The Company was incorporated in 1986 and became a public limited company in 1992. The shares were listed on the stock exchanges in 1995 for the first time. |
 |
|
What is the contact address to communicate?
Registered & Corporate Office
Aurobindo Pharma Limited
Plot # 2, Maitri Vihar, Ameerpet,
Hyderabad – 500 038
Andhra Pradesh, India.
Phone: +91 (40) 6672 5000
Fax: +91(40) 2374 1080 / 2374 6833
Email : cs@aurobindo.com |
|
|
Where are your overseas offices? How do I contact them?
Please refer to Corporate Information in this website. You will find all the addresses provided in the ‘Subsidiaries / Overseas Offices’ section. |
 |
|
|
What are the key business segments of Aurobindo Pharma? What are the key markets that the Company operates?
Aurobindo Pharma is a fast track integrated pharmaceutical company headquartered in Hyderabad, India, producing and marketing some of the most quality conscious Active Pharmaceutical Ingredients (APIs or bulk actives), intermediates and speciality generic formulations.
The company’s robust product portfolio is spread over 6 major product areas (encompassing Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment.
It ranks among the top 5 pharma companies in India and is a multi product, multi technology, transnational company. Today, the Company’s products are serving consumers in India and over 100 other countries. |
|
|
|
|
|
I am a well qualified person, and would like to work with Aurobindo Pharma. Can I join you? Are you recruiting?
Aurobindo Pharma needs effective and result oriented human resources, who can further improve the pace of progress. And, who seek joy and challenges of working as a team. If you wish to join the Aurobindo Family, please refer to Career Opportunities in this website. Do forward your resume and we shall revert after considering the specific needs. |
|
|
|
Do you have any plans to increase your dividend?Aurobindo Pharma has increased its dividend a number of times over the last several years (adjusted for bonus issues). The Board of Directors considers the appropriate level of dividends while announcing the annual financial results, when the dividend is declared. The following table shows the distribution pattern in the last seven years:
| Year |
Rate % |
Bonus |
| 1997 - 1998 |
50 |
1:1 |
| 1998 - 1999 |
50 |
|
| 1999 - 2000 |
50 |
|
| 2000 - 2001 |
30 |
1:1 |
| 2001 - 2002 |
30 |
|
| 2002 - 2003 |
35 |
|
| 2003 - 2004 |
45 |
|
| 2004 - 2005 |
10 |
|
| 2005 - 2006 |
30 |
|
The Company believes that it is in the best interest of stockholders to reinvest the retained earnings into the future of the Company in research and development. In addition, cash is used for expansion of manufacturing facilities. |
|
|
Do you have any plans to issue bonus shares?
Aurobindo Pharma has had two bonus issues in the last five years, each time in the ratio of 1:1. The most recent one was effective 07 April, 2000. The Board of Directors is conscious of the investor interest, and makes any decision for bonus issues at the appropriate time. The Board of the Company believes in improving shareholder wealth, and considers all matters from the perspective of the small investor. |
|
|
What is the Company’s financial year?
The financial year of the Company is 1st April to 31st March. |
|
|
|
Does the Company issue quarterly results?
Normally, within one month from end of the quarter, the Board of Directors reviews the performance of the quarter, and announces the financial results. These are widely published in newspapers, as well as placed on this website. Please see Quarterly Results under the ‘Financial Results' section in this website |
|
|
What accounting firm audits your financial statements?
The Company’s accounts are audited by M/s. S.R.Batliboi & Co, a well-known firm of Chartered Accountants and a member firm of Ernst & Young. |
|
|
What is the face (par) (paid-up) value of Aurobindo Pharma share? What is the market lot?
The face value is Rs.5 per share. The market lot is one share. |
|
|
|
I am a prospective investor in Aurobindo Pharma. Where can I get the shares? Are you issuing any shares?
Aurobindo Pharma shares can be bought or sold through a stockbroker, or generally through a financial institution that provides brokerage services. The shares are traded on compulsory demat mode. The Company, at present, is not directly issuing shares. |
|
|
When was the last Annual General Meeting (AGM) of shareholders? When is the next meeting?
The last AGM was held on September 18, 2006. The next meeting will be held after an appropriate announcement in 2007. |
|
|
How do I transfer my shares?
The shares of the Company are freely tradeable, and can be transferred to any person. There are no restrictions on transfer. Please consult a Depository Participant, who will help you to register the shares in your name. |
|
|
|
When was the last book closure date?
The Book Closure for Annual General Meeting and payment of dividend was from Tuesday, September 12 to Monday, September 18, 2006 (both days inclusive). |
|
|
How do I change my address registered with the transfer agent?Please intimate the Registrar & Transfer Agents of the Company. Their contact details are: M/s. Karvy Computershare Private Limited,
46 Avenue 4, Street # 1,
Banjara Hills,
Hyderabad – 500034.
Tel. +91(40) 2342 0818 to 0825
Fax +91(40) 2331 0814
Email: mailmanager@karvy.com |
|
|
|
|
|
|
Where are the Company’s shares listed?
The Company’s shares are listed and traded on
The Hyderabad Stock Exchange Limited,
The Bombay Stock Exchange Limited, Mumbai,
The National Stock Exchange of India Limited. |
|
|
What is the Stock Code?The stock codes are:
| ISIN |
: |
INE 406A01029 |
| Stock Code (BSE) |
: |
524804 |
| Stock Code (NSE) |
: |
AUROPHARMA |
| Stock Code (HSE) |
: |
ABD |
| Reuters Code |
: |
ARBN.BO |
| Bloomberg Code |
: |
ARBP.IN |
|
|
